Amneal Pharmaceuticals
AMRX
AMRX
236 hedge funds and large institutions have $1.14B invested in Amneal Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 106 increasing their positions, 57 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
236
Holders Change
+2
Holders Change %
+0.85%
% of All Funds
3.16%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
106
Reduced
57
Closed
30
Calls
$1.79M
Puts
$556K
Net Calls
+$1.23M
Net Calls Change
-$761K
Top Buyers
| 1 |
Millennium Management
New York
|
+$23.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.5M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$12.4M |
| 4 |
Goldman Sachs
New York
|
+$10.5M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.88M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$15.1M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$12.6M |
| 3 |
HAI
Hennessy Advisors Inc
Novato,
California
|
-$12.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$8.89M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.73M |
